AMMEDICS, a Korean biomaterials company, to join the January 2023 Korea-United Arab Emirates (UAE) Economic Forum, announced that they had signed a contract with a local buyer in the UAE.

Established in 2019, AMMEDICS is a Korean biomaterials specialist that researches and develops biomaterial peptides through biotechnology-based R&D and applies them to manufacture medical devices and cosmetics, including skin booster fillers and dermal fillers.

The size of the Middle East beauty market, where Korean biomaterials company AMMEDICS has taken its first step, is worth about tpf=news/view&code=625.3 billion US, and the annual per capita income is ,348. It is a market with high purchasing power, high potential, and investment value.

The trend is shifting from color cosmetics were popular in the past to the personal care segment recently, which accounted for the largest share of market revenue at 8.8 million, followed by skincare and cosmetics.

AMMEDICS, a Korean biomaterials company, to join the January 2023 Korea-United Arab Emirates (UAE) Economic Forum, announced that they had signed a contract with a local buyer in the UAE.

Established in 2019, AMMEDICS is a Korean biomaterials specialist that researches and develops biomaterial peptides through biotechnology-based R&D and applies them to manufacture medical devices and cosmetics, including skin booster fillers and dermal fillers.

The size of the Middle East beauty market, where Korean biomaterials company AMMEDICS has taken its first step, is worth about tpf=news/view&code=625.3 billion US, and the annual per capita income is ,348. It is a market with high purchasing power, high potential, and investment value.

The trend is shifting from color cosmetics were popular in the past to the personal care segment recently, which accounted for the largest share of market revenue at 8.8 million, followed by skincare and cosmetics.